However, while the levels of sHLA-G in patients with ovarian cancer and deep endometriosis remained elevated during further stages of the cycle as well, a significant decrease in this parameter was observed during the secretory phase in women with ovarian endometrioma. The gene discussed is HLA-G; the disease is ovarian carcinoma.